Black Creek Investment Management Inc. Increases Stock Position in Lam Research Corporation $LRCX

Black Creek Investment Management Inc. lifted its stake in Lam Research Corporation (NASDAQ:LRCX) by 358.7% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 118,269 shares of the semiconductor company’s stock after acquiring an additional 92,488 shares during the quarter. Lam Research accounts for about 0.5% of Black Creek Investment Management Inc.’s investment portfolio, making the stock its 18th largest holding. Black Creek Investment Management Inc.’s holdings in Lam Research were worth $11,512,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. IMG Wealth Management Inc. bought a new stake in Lam Research in the 2nd quarter worth approximately $26,000. REAP Financial Group LLC purchased a new position in shares of Lam Research in the 2nd quarter worth $31,000. Bank of Jackson Hole Trust boosted its stake in shares of Lam Research by 111.1% in the 2nd quarter. Bank of Jackson Hole Trust now owns 380 shares of the semiconductor company’s stock worth $37,000 after buying an additional 200 shares during the last quarter. Barnes Dennig Private Wealth Management LLC bought a new stake in shares of Lam Research in the second quarter worth $38,000. Finally, Hilltop National Bank purchased a new stake in Lam Research during the second quarter valued at $38,000. Institutional investors own 84.61% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts have issued reports on LRCX shares. BNP Paribas Exane raised their target price on Lam Research from $80.00 to $140.00 and gave the stock a “neutral” rating in a research report on Thursday, October 23rd. Argus raised their price objective on shares of Lam Research from $105.00 to $120.00 and gave the stock a “buy” rating in a report on Friday, August 1st. Wall Street Zen lowered shares of Lam Research from a “buy” rating to a “hold” rating in a research report on Saturday, November 8th. Susquehanna increased their price target on shares of Lam Research from $135.00 to $200.00 and gave the stock a “positive” rating in a research report on Thursday, October 23rd. Finally, UBS Group set a $165.00 price target on shares of Lam Research and gave the stock a “buy” rating in a research note on Thursday, October 23rd. One analyst has rated the stock with a Strong Buy rating, twenty-six have given a Buy rating and nine have issued a Hold rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $149.04.

Insiders Place Their Bets

In other Lam Research news, SVP Vahid Vahedi sold 52,190 shares of the company’s stock in a transaction that occurred on Monday, October 13th. The stock was sold at an average price of $138.90, for a total value of $7,249,191.00. Following the completion of the transaction, the senior vice president directly owned 251,047 shares in the company, valued at $34,870,428.30. This represents a 17.21% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CFO Douglas R. Bettinger sold 40,080 shares of Lam Research stock in a transaction that occurred on Friday, November 14th. The shares were sold at an average price of $150.60, for a total transaction of $6,036,048.00. Following the sale, the chief financial officer owned 987,237 shares in the company, valued at approximately $148,677,892.20. The trade was a 3.90% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders have sold 102,608 shares of company stock valued at $14,916,496. 0.31% of the stock is owned by company insiders.

Lam Research Stock Down 0.5%

Shares of LRCX stock opened at $147.46 on Tuesday. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.21 and a quick ratio of 1.60. Lam Research Corporation has a one year low of $56.32 and a one year high of $167.15. The company’s fifty day moving average price is $141.60 and its 200-day moving average price is $110.47. The company has a market capitalization of $185.21 billion, a price-to-earnings ratio of 32.48, a PEG ratio of 1.68 and a beta of 1.87.

Lam Research (NASDAQ:LRCX) last issued its earnings results on Wednesday, October 22nd. The semiconductor company reported $1.26 earnings per share for the quarter, topping the consensus estimate of $1.22 by $0.04. The company had revenue of $5.32 billion during the quarter, compared to the consensus estimate of $5.23 billion. Lam Research had a net margin of 29.66% and a return on equity of 60.60%. Lam Research’s quarterly revenue was up 27.7% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.86 EPS. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS. Sell-side analysts expect that Lam Research Corporation will post 3.71 EPS for the current fiscal year.

Lam Research Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, January 7th. Investors of record on Wednesday, December 3rd will be paid a dividend of $0.26 per share. This represents a $1.04 annualized dividend and a yield of 0.7%. The ex-dividend date of this dividend is Wednesday, December 3rd. Lam Research’s dividend payout ratio (DPR) is 22.91%.

About Lam Research

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.